SynCore Biotechnology Co.,Ltd announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 2.039 million compared to TWD 2.007 million a year ago. Operating loss was TWD 112.738 million compared to TWD 81.326 million a year ago. Net loss was TWD 110.785 million compared to TWD 80.816 million a year ago. Basic loss per share was TWD 1.22 compared to TWD 1.02 a year ago. For the nine months, sales was TWD 10.841 million compared to TWD 5.778 million a year ago. Operating loss was TWD 300.773 million compared to TWD 203.529 million a year ago. Net loss was TWD 296.367 million compared to TWD 201.874 million a year ago. Basic loss per share was TWD 3.38 compared to TWD 2.75 a year ago.